Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
								
																		
									
																											
																		
									
																											
																		
									
										
											Monoisotopic mass 
										
										
											486.222682722										
									 
																											
									
																		
									
										
											InChI 
										
										
											InChI=1S/C23H30N6O6/c1-3-25-21(32)18-16(30)17(31)22(35-18)29-11-26-15-19(24)27-14(28-20(15)29)6-4-5-12-7-9-13(10-8-12)23(33)34-2/h11-13,16-18,22,30-31H,3,5,7-10H2,1-2H3,(H,25,32)(H2,24,27,28)/t12?,13?,16?,17?,18-,22+/m0/s1										
									 
																		
																		
										
											InChI Key 
										
										
											InChIKey=FLEVIENZILQUKB-FFFDGBMNSA-N										
									 
																											
																		
										
											IUPAC Name 
										
										
											methyl 4-(3-{6-amino-9-[(2R,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]-9H-purin-2-yl}prop-2-yn-1-yl)cyclohexane-1-carboxylate										
									 
																											
																		
										
											Traditional IUPAC Name 
										
										
											methyl 4-(3-{6-amino-9-[(2R,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl}prop-2-yn-1-yl)cyclohexane-1-carboxylate										
									 
																											
									
																		
										
											SMILES 
										
										
											CCNC(=O)[C@H]1O[C@H](C(O)C1O)N1C=NC2=C(N)N=C(N=C12)C#CCC1CCC(CC1)C(=O)OC										
									 
																		
																		
									
																		
																		
																		
																											
																		
																											
																		
																											
																		
										
											pKa (strongest acidic) 
										
										
											12.39										
									 
																											
																		
										
											pKa (Strongest Basic) 
										
										
											2.97										
									 
																											
																		
																											
																		
										
											Refractivity 
										
										
											121.62 m3·mol-1
										
									 
																			  
		  
																		
																											
																		
																		
									
																		
																		
																		
																		
																		
																		
																		
																		
											  
		  
								 
							 	
														
														
															
								 Cơ Chế Tác Dụng : 
								
									BMS068645 is a selective A2a adenosine receptor agonist designed for use as a pharmacologic stress agent in cardiac perfusion imaging studies. It is developed by Bristol-Myers Squibb and is in phase II of clinical trials.								
								
									BMS068645 is designed to selectively stimulate the A2a adenosine receptor responsible for coronary vasodilation. Research to date suggests that this compound could potentially reduce or eliminate side effects associated with currently available pharmacologic stress agents that are not selective for the A2a adenosine receptor.								
							
														
														
														
							
																					
								 Chỉ Định : 
								
									Investigated for use/treatment in cardiovascular disorders and inflammatory disorders (unspecified).